Literature DB >> 17825858

A systematic analysis of influenza vaccine shortage policies.

Lori Uscher-Pines1, Daniel J Barnett, Jason W Sapsin, David M Bishai, Ran D Balicer.   

Abstract

OBJECTIVES: The aim of this study was to apply SWOT analysis (strengths, weaknesses, opportunities, threats) to a domestic shortage of influenza vaccine, to identify lessons learned, and to generate effective solutions for future public health rationing emergencies. STUDY DESIGN/
METHODS: SWOT and TOWS techniques were employed to characterize the vulnerability of the USA to disruptions in the supply of influenza vaccine. A group of five researchers reviewed relevant literature, engaged in group brainstorming, and categorized elements according to the SWOT framework.
RESULTS: Three strengths, five weaknesses, five threats and seven opportunities were identified in the areas of vaccine production, purchasing and distribution, and provision. Four future recommendations emerged with respect to government investment, communications, sanctioning of physicians, and incident command.
CONCLUSIONS: Application of the SWOT technique is highly relevant to the health policy realm and can assist public health planners in planning for future resource scarcity.

Mesh:

Substances:

Year:  2007        PMID: 17825858     DOI: 10.1016/j.puhe.2007.06.005

Source DB:  PubMed          Journal:  Public Health        ISSN: 0033-3506            Impact factor:   2.427


  11 in total

1.  Meeting global health challenges through operational research and management science.

Authors:  Geoff Royston
Journal:  Bull World Health Organ       Date:  2011-07-05       Impact factor: 9.408

2.  Assessment of Prospective Physician Characteristics by SWOT Analysis.

Authors:  Woratanarat Thira; Woratanarat Patarawan
Journal:  Malays J Med Sci       Date:  2012-01

3.  Economics of influenza vaccine administration timing for children.

Authors:  Bruce Y Lee; Julie H Y Tai; Rachel R Bailey; Kenneth J Smith; Andrew J Nowalk
Journal:  Am J Manag Care       Date:  2010-03       Impact factor: 2.229

4.  The timing of influenza vaccination for older adults (65 years and older).

Authors:  Bruce Y Lee; Julie H Y Tai; Rachel R Bailey; Kenneth J Smith
Journal:  Vaccine       Date:  2009-09-26       Impact factor: 3.641

5.  Analyzing and strengthening the vaccine safety program in Manitoba.

Authors:  J M Montalban; C Ogbuneke; T Hilderman
Journal:  Can Commun Dis Rep       Date:  2014-12-04

6.  Nanorobot Hardware Architecture for Medical Defense.

Authors:  Adriano Cavalcanti; Bijan Shirinzadeh; Mingjun Zhang; Luiz C Kretly
Journal:  Sensors (Basel)       Date:  2008-05-06       Impact factor: 3.576

Review 7.  Prioritising access to pandemic influenza vaccine: a review of the ethics literature.

Authors:  Jane H Williams; Angus Dawson
Journal:  BMC Med Ethics       Date:  2020-05-14       Impact factor: 2.652

Review 8.  Matrix and backstage: cellular substrates for viral vaccines.

Authors:  Ingo Jordan; Volker Sandig
Journal:  Viruses       Date:  2014-04-11       Impact factor: 5.048

Review 9.  Elements in the Development of a Production Process for Modified Vaccinia Virus Ankara.

Authors:  Ingo Jordan; Verena Lohr; Yvonne Genzel; Udo Reichl; Volker Sandig
Journal:  Microorganisms       Date:  2013-11-01

Review 10.  A Review of DNA Vaccines Against Influenza.

Authors:  Leo Yi Yang Lee; Leonard Izzard; Aeron C Hurt
Journal:  Front Immunol       Date:  2018-07-09       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.